JONATHAN D. ROOT - 22 Jul 2025 Form 3 Insider Report for CARLSMED, INC. (CARL)

Role
Director
Signature
/s/ Leonard Greenstein, as attorney-in-fact for Jonathan Root
Issuer symbol
CARL
Transactions as of
22 Jul 2025
Transactions value $
$0
Form type
3
Filing time
22 Jul 2025, 17:31:13 UTC
Previous filing
08 Jul 2025
Next filing
07 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ROOT JONATHAN D Director C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD /s/ Leonard Greenstein, as attorney-in-fact for Jonathan Root 22 Jul 2025 0001225480

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CARL Series A Preferred Stock 22 Jul 2025 Common Stock 2.95M See Footnotes F1, F4, F5
holding CARL Series B Preferred Stock 22 Jul 2025 Common Stock 825K See Footnotes F1, F4, F5
holding CARL Series C Preferred Stock 22 Jul 2025 Common Stock 532K See Footnotes F1, F4, F5
holding CARL Series A Preferred Stock 22 Jul 2025 Common Stock 150K See Footnotes F2, F4, F5
holding CARL Series B Preferred Stock 22 Jul 2025 Common Stock 41.9K See Footnotes F2, F4, F5
holding CARL Series C Preferred Stock 22 Jul 2025 Common Stock 27K See Footnotes F2, F4, F5
holding CARL Series C Preferred Stock 22 Jul 2025 Common Stock 1.12M See Footnotes F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock held by U.S. Venture Partners XII, L.P. ("USVP XII").
F2 Stock held by U.S. Venture Partners XII-A, L.P. ("USVP XII-A").
F3 Stock held by U.S. Venture Partners Select Fund I, L.P. ("USVP SFI"), on its own behalf and as nominee for U.S. Venture Partners Select Fund I-A, L.P. ("USVP SFI-A").
F4 Presidio Management Group XII, L.L.C ("PMG XII") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C ("PMG SFI," and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, "USVP") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein.
F5 These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the "Reverse Split"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis and have no expiration date.